Asia
Singapore· SingaporeiX Biopharma Addresses Orion Speciality Labs' Licensing Status
iX Biopharma stated that Orion Speciality Labs' lack of a state license is expected at this current stage of development.
Background
This story is part of a broader trend of increased scrutiny on pharmaceutical companies' regulatory compliance and licensing across various jurisdictions. Governments and public health bodies are tightening oversight to ensure product safety and market integrity, impacting both established firms and emerging biotechs.
Quorum · collective opinions
iX Biopharma Addresses Orion Speciality Labs' Licensing Status
First report 17h agoLast update 17h ago1 takes 1
company statementneutralShow 1 post
started 17h ago•Last update 17h ago
The company provided a statement regarding the licensing status of its subsidiary.
iWitness comments
No comments yet — be the first to weigh in.